Literature DB >> 7907436

Bronchodilators and bronchial hyperresponsiveness.

D R Taylor, M R Sears.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907436      PMCID: PMC474349          DOI: 10.1136/thx.49.2.190

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  14 in total

1.  Bronchial responsiveness during regular fenoterol therapy: four months prospective study.

Authors:  G I Town; T V O'Donnell; G Purdie
Journal:  N Z Med J       Date:  1991-01-23

2.  Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.

Authors:  C P van Schayck; S J Graafsma; M B Visch; E Dompeling; C van Weel; C L van Herwaarden
Journal:  J Allergy Clin Immunol       Date:  1990-11       Impact factor: 10.793

3.  Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.

Authors:  A S Vathenen; A J Knox; B G Higgins; J R Britton; A E Tattersfield
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

4.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

Authors:  J Kraan; G H Koëter; T W vd Mark; H J Sluiter; K de Vries
Journal:  J Allergy Clin Immunol       Date:  1985-10       Impact factor: 10.793

5.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.

Authors:  T Haahtela; M Järvinen; T Kava; K Kiviranta; S Koskinen; K Lehtonen; K Nikander; T Persson; K Reinikainen; O Selroos
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

6.  Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma.

Authors:  M Raes; P Mulder; K F Kerrebijn
Journal:  J Allergy Clin Immunol       Date:  1989-12       Impact factor: 10.793

7.  A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.

Authors:  H A Kerstjens; P L Brand; M D Hughes; N J Robinson; D S Postma; H J Sluiter; E R Bleecker; P N Dekhuijzen; P M de Jong; H J Mengelers
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

8.  Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.

Authors:  K F Kerrebijn; E E van Essen-Zandvliet; H J Neijens
Journal:  J Allergy Clin Immunol       Date:  1987-04       Impact factor: 10.793

9.  Regular inhaled beta-agonist treatment in bronchial asthma.

Authors:  M R Sears; D R Taylor; C G Print; D C Lake; Q Q Li; E M Flannery; D M Yates; M K Lucas; G P Herbison
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

10.  Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine.

Authors:  E T Peel; G J Gibson
Journal:  Am Rev Respir Dis       Date:  1980-06
View more
  5 in total

Review 1.  Anomalous effects of albuterol and other sympathomimetics in the guinea pig.

Authors:  J Morley
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

2.  Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma.

Authors:  M Perrin-Fayolle; P S Blum; J Morley; M Grosclaude; M T Chambe
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

Review 3.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 4.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 5.  Evidence based review on levosalbutamol.

Authors:  Mukesh Kumar Gupta; Meenu Singh
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 5.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.